Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
West Indian med. j ; 62(1): 56-61, Jan. 2013. tab
Article in English | LILACS | ID: biblio-1045588

ABSTRACT

OBJECTIVES: Although common worldwide, intravaginal cleansing is associated with poor health outcomes. We sought to describe intravaginal cleansing among women attending a sexually transmitted infection (STI) clinic in Jamaica. METHODS: We examined intravaginal cleansing ("washing up inside the vagina", douching, and products or materials used) among 293 participants in a randomized trial of counselling messages at an STI clinic in Kingston. We focussed on information on intravaginal cleansing performed in the 30 days and three days preceding their baseline study visit. We describe reported cleansing behaviours and used logistic regression to identify correlates of intravaginal cleansing RESULTS: Fifty-eight per cent of participants reported intravaginal cleansing in the previous 30 days, and 46% did so in the three days before baseline. Among those who cleansed in the previous 30 days, 88% reported doing so for hygiene unrelated to sex, and three-fourths reported generally doing so more than once per day. Soap (usually with water) and water alone were the most common products used for washing; commercial douches or detergents were reported infrequently. Intravaginal cleansing in the three days before the baseline visit was positively associated with having more than one sex partner in the previous three months (adjusted odds ratio [AOR], 1.9; 95% CI, 1.1, 3.2), and negatively associated with experiencing itching in the genital area at baseline (AOR, 0.6; 95% CI, 0.4, 1.0). CONCLUSIONS: A large proportion of women attending STI clinics in Jamaica engage in frequent intravaginal cleansing, indicating a need for clinicians to discuss this topic with them accordingly.


OBJETIVOS: Aunque común mundialmente, la limpieza intravaginal se halla asociada con pobres resultados de salud. Buscamos describir la limpieza intravaginal entre mujeres que asisten a una clínica de infecciones de transmisión sexual (ITS) en Jamaica. MÉTODOS: Examinamos la limpieza intravaginal ("lavado del interior de la vagina", ducha, y productos o materiales usados) entre 293 participantes en una prueba aleatoria de mensajes de counseling en una clínica de ITS en Kingston. Las participantes proporcionaron la información sobre la limpieza intravaginal realizada en los 30 y tres días que precedieron a su visita para el estudio inicial. Describimos las conductas de limpieza reportadas y la regresión logística usada para identificar los correlatos de la limpieza intravaginal. RESULTADOS: Cincuenta y ocho por ciento de las participantes reportaron la limpieza intravaginal en los 30 días anteriores, y el 46% lo hicieron en los tres días antes del inicio del estudio. Entre aquéllas que realizaron la limpieza en los 30 días anteriores, el 88% reportó haberlo hecho por razones de higiene independientes de la vida sexual, y tres cuartos reportaron hacerlo de manera general más de una vez al día. Jabón (normalmente con agua) y agua solamente fueron los productos más comunes usados para el lavado. Las duchas comerciales o detergentes no fueron reportadas muy frecuentemente. La limpieza intravaginal en los tres días antes de la visita del estudio inicial estuvo positivamente asociada con tener más de una pareja sexual en los tres meses anteriores (odds ratio ajustado [AOR], 1.9; 95% CI, 1.1, 3.2), y negativamente asociado con experimentar comezón en el área genital al inicio del estudio (AOR, 0.6; 95% CI, 0.4, 1.0). CONCLUSIONES: Un gran número de mujeres que asisten a las clínicas de ITS en Jamaica practican frecuentemente la limpieza intravaginal, lo cual indica la necesidad de que los médicos clínicos discutan este asunto con ellas.


Subject(s)
Humans , Female , Adult , Sexual Behavior , Health Behavior , Sexually Transmitted Diseases/prevention & control , Vaginal Douching , Soaps/therapeutic use , Time Factors , Sexual Partners , Logistic Models , Treatment Outcome , Ambulatory Care Facilities , Jamaica
2.
Rev. Fac. Med. (Bogotá) ; 51(1): 25-31, ene.-mar. 2003. tab
Article in Spanish | LILACS | ID: lil-424539

ABSTRACT

Los mecanismos moleculares que originan la aterosclerosis no están claros, sin embargo se conoce que anormalidades en las señales mediadas por las especies reactivas de oxígeno (ERO) y de nitrógeno (ERN) pueden desencadenar la patogénesis de la enfermedad cuando se asocian con factores de riesgo como hiperlipidemia, hiperglicemia y cambios en las fuerzas hemodinámicas. En esta revisión nos proponemos resaltar los diferentes mecanismos desencadenados por las ERO y ERN que llevan al desarrollo de la aterogénesis incluyendo la regulación de la transcripción de varios genes


Subject(s)
Arteriosclerosis/etiology , Free Radicals
3.
Braz. j. med. biol. res ; 36(2): 143-151, Feb. 2003. ilus
Article in English | LILACS | ID: lil-326425

ABSTRACT

Oligonucleotides have a wide range of applications in fields such as biotechnology, molecular biology, diagnosis and therapy. However, the spectrum of uses can be broadened by introducing chemical modifications into their structures. The most prolific field in the search for new oligonucleotide analogs is the antisense strategy, where chemical modifications confer appropriate characteristics such as hybridization, resistance to nucleases, cellular uptake, selectivity and, basically, good pharmacokinetic and pharmacodynamic properties. Combinatorial technology is another research area where oligonucleotides and their analogs are extensively employed. Aptamers, new catalytic ribozymes and deoxyribozymes are RNA or DNA molecules individualized from a randomly synthesized library on the basis of a particular property. They are identified by repeated cycles of selection and amplification, using PCR technologies. Modified nucleotides can be introduced either during the amplification procedure or after selection


Subject(s)
Humans , Drug Design , Oligonucleotides , Gene Library , Genetic Therapy , Oligonucleotides , Oligonucleotides, Antisense , RNA, Catalytic
4.
Rio de Janeiro; s.n; s.ed; 2003. 27p
Non-conventional in English | LILACS, SES-SP, HANSEN, HANSENIASE, SESSP-ILSLACERVO, SES-SP | ID: biblio-1241432

ABSTRACT

Este trabalho é um resultado preliminar de pesquisa sobre a memória e história da hanseníase, deseenvolvida pela Fundação Oswaldo Cruz (Fiocruz) e Universidade Federal do Rio de Janeiro (UFRJ), através de depoimentos de quem padeceu da doença ou atuou contra ela. Apresenta as opções metodológicas adotadas pelos autores, um sucinto histórico da hanseníase no Brasil e dados a respeito do estágio em que se encontra a pesquisa, com extratos de depoimentos que constituem o acervo gerado. Na década de 1980 houve avanços, como a adoção do tratamento através da poliquimioterapia, que provocou a redução do índice de prevalência da doença, que passou de 16,3 casos por dez mil habitantes em 1985, para 4,57 casos para dez mil habitantes em 2000, em nosso país. A gênese e as atividades do Movimento de Reintegração das Pessoas Atingidas pela Hanseníase (Morban) são reveladas pelos testemunhos de Thomas Frist, cientista social norte-americano que trabalhou no Brasil nas décadas de 1970 e 1980, período de reestruturação das antigas colônias, e pelo de Cristiano Torres, ex-paciente, com passagens por preventórios e leprosários no Pará, personagem atuante, inclusive na proposição de políticas de controle da hanseníase


Subject(s)
Leprosy/history , Leper Colonies/history
5.
Indian J Lepr ; 1996 Jul-Sep; 68(3): 235-45
Article in English | IMSEAR | ID: sea-55196

ABSTRACT

This study compares the clinical, bacilloscopic, and histopathological evolution of 140 patients classified as having multibacillary leprosy with no previous specific treatment who were submitted to two multidrug treatment regimens with a fixed dose. Regimen I-Group 1: 70 cases received 600 mg rifampicin (RMP) + 100 mg dapsone (DDS) daily for three consecutive months followed by 100 mg DDS daily, self-administered doses for 21 months. Regimen II-Group II: 70 cases received 600 mg RMP + 300 mg clofazimine (CLO) once a month under supervision plus self-administered doses of 50 mg CLO + 100 mg DDS daily for 24 months. The bacilloscopic, histopathological and neuromotor evaluation parameters showed no statistically meaningful differences (P > 0.05) between the two groups except for reaction frequency (P < 0.05) in that group II patients presented the least number of reactional episodes during the treatment and in the dermatological examination at discharge. Follow-up after treatment was carried out for a consecutive four year period. During routine clinical examination one case submitted to regimen I developed nodular skin lesion over the right arm. Skin biopsy was done for histopathological examination and mouse foot-pad experiment by Shepard technique. The drug susceptibility test with DDS and RPM showed that M. leprae strain isolated was susceptible to both the drugs.


Subject(s)
Adolescent , Adult , Aged , Animals , Clofazimine/therapeutic use , Dapsone/therapeutic use , Female , Follow-Up Studies , Humans , Leprostatic Agents/therapeutic use , Leprosy, Borderline/drug therapy , Leprosy, Lepromatous/drug therapy , Male , Mice , Middle Aged , Retrospective Studies , Rifampin/therapeutic use , Sex Distribution , Treatment Outcome
6.
Braz. j. med. biol. res ; 24(5): 441-8, 1991. tab
Article in English | LILACS | ID: lil-99475

ABSTRACT

Since dot-ELISA has recently been reported to be a sensitive, simple and method, we have compared it with the conventional microplate ELISA method. Sera of 124 leprosy patients, 136 household and professional contacts, and 92 controls were tested for a antibodies against a Mycobacterium leprae antigen using dot-ELISA on nitrocellulose membrane filters and microplate ELISA. The sensitive of the techniques was similar for multibacillary patients, but dot-ELISA was less sensitive for paucibacillary patients although it was more specific (100%) than ELISA (93,4%). Of 21 household contacts that gave a response by ELISA, 3 were also positive by dot-ELISA; one of these 3 developed indeterminate leprosy 12 months later and the other was diagnosed as borderline lepromatous after 28 months. These data indicate that dot-ELISA has a high spedificity and can be a useful tool in field evaluation


Subject(s)
Humans , Antigens, Bacterial/blood , Enzyme-Linked Immunosorbent Assay/methods , Glycolipids/immunology , Immunoblotting/methods , Immunoglobulin M/analysis , Leprosy/diagnosis , Leprosy, Borderline/diagnosis , Leprosy, Borderline/immunology , Leprosy, Borderline/transmission , Leprosy, Lepromatous/diagnosis , Leprosy, Lepromatous/immunology , Leprosy, Lepromatous/transmission , Leprosy, Tuberculoid/diagnosis , Leprosy, Tuberculoid/immunology , Leprosy, Tuberculoid/transmission , Leprosy/immunology , Leprosy/transmission , Predictive Value of Tests , Skin/immunology
7.
Braz. j. med. biol. res ; 24(8): 801-5, 1991. ilus
Article in English | LILACS | ID: lil-102067

ABSTRACT

Cutaneous reaction to the Mitsuda antigen and anti-PGL-I IgM antibodies (ELISA) were determined in 134 leprosy patients, 290 household contacts, 52 healthy controls and 43 tuberculous individuals. The multibacillary patients did nort developed cell-mediated immunity (CMI), although they presented high levels of IgM (absorbance at 492 m > 0.5). The paucibacillatry patients presented CMI, although in varying degrees, and IgM levels did not exceed 0.5 absorbance units. Most of the contacts (107) showed a Mitsuda-postive test, and 25 of then were anti-PGL-I IgM seropositive (absorbance < 0.5 but > 0.22), although none became ill during the twoyear follow-up. Of the 17 Mitsuda-negative contacts, two wxhibited an immunological status of lepromatous leprosy (negative Mitsuda test and positive serology; absorvance > 0.05) and became ill (one borderline lepromatous and one indeterminate leprosy). These results show that the immunological status of lepromatous leprosy can appear prior to clinical symptoms, and thus serology for anti-PGL-I IgM together with the Mitsuda test can be useful in an activbe search for new preclinical cases among high risk populations


Subject(s)
Humans , Glycolipids , Leprosy/diagnosis , Antibodies, Anti-Idiotypic , Antigens, Bacterial/analysis , Enzyme-Linked Immunosorbent Assay , Immunoglobulin M/analysis , Mycobacterium leprae/immunology , Skin Tests
8.
Mem. Inst. Oswaldo Cruz ; 85(2): 191-4, abr.-jun. 1990. tab
Article in English | LILACS | ID: lil-90853

ABSTRACT

For the first time in Brazil it was investigated the occurrence of IgM anti-PGL-1 in the sera of household contacts of leprozy patients using the ELISA methodology. The sera of the multipatients. It was observed a high subclinical infection incidence among household contacts (19.4%). The percentage of leprosy development was 5% (1/21) among the seropositive contact group. This finding suggests that serology could be useful as prognostic test, but for better definition is necessary to tet a population from endemic area for long period time


Subject(s)
Child , Adolescent , Adult , Middle Aged , Humans , Male , Female , Antigens, Bacterial/analysis , Enzyme-Linked Immunosorbent Assay , Leprosy/immunology , Immunoglobulin M/analysis , Mycobacterium leprae/immunology , Brazil , Follow-Up Studies , Leprosy/diagnosis , Prognosis
9.
An. bras. dermatol ; 59(4): 159-62, 1984.
Article in Portuguese | LILACS | ID: lil-22984

ABSTRACT

Foram analisadas 100 alteracoes nas impressoes digitais de hansenianos controlados no Ambulatorio Souza Araujo.Comparamos as impressoes digitais de cada paciente com as individuais arquivadas no Instituto de Identificacao Felix Pacheco, tomadas na epoca da identificacao civil.Os resultados obtidos sugerem o uso da tecnica de tomada de impressoes digitais como mais uma forma de se observar a evolucao clinica do paciente, atraves da regressao ou manutencao das alteracoes durante o tratamento e como possivel metodo de triagem, descobrindo portador real ou potencial da doenca


Subject(s)
Humans , Dermatoglyphics , Leprosy
SELECTION OF CITATIONS
SEARCH DETAIL